Lifecycle management of orphan drugs approved in Japan

被引：0
|
作者：
Kiyoshi Seki
Hiroshi Suzuki
Seiji Abe
Chikako Saotome
机构：
[1] Kyoto University Graduate School of Medicine,
来源：
Orphanet Journal of Rare Diseases | / 17卷
关键词：
Orphan drug; Life cycle management; New indication approval; Patent; Re-examination term; Market exclusivity; Generics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Characteristics of drugs approved in Japan without conducting confirmatory clinical trials
    Izuka, Shunsuke
    Matsumaru, Naoki
    Tsukamoto, Katsura
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (06) : 1582 - 1590
  • [42] CDK Inhibitors and FDA: Approved and Orphan
    Cicenas, Jonas
    Simkus, Jokubas
    [J]. CANCERS, 2024, 16 (08)
  • [43] ORPHAN DRUGS
    LYLE, WH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (15): : 813 - 814
  • [44] ORPHAN DRUGS
    BLANCHARD, T
    [J]. NATURE, 1992, 358 (6387) : 534 - 534
  • [45] Orphan drugs
    Messori, Andrea
    Attanasio, Francesco
    Trippoli, Sabrina
    Banfi, Roberto
    [J]. LANCET, 2019, 393 (10181): : 1595 - 1595
  • [46] Orphan drugs
    Burke, Maria
    [J]. CHEMISTRY & INDUSTRY, 2013, 77 (09) : 38 - 41
  • [47] ORPHAN DRUGS
    SCHIFFRIN, MJ
    [J]. ANNALS OF ALLERGY, 1982, 48 (01): : 63 - 65
  • [48] Orphan Drugs
    Schaefer, Juergen R.
    Vogelmeier, Claus F.
    [J]. INTERNIST, 2019, 60 (04): : 396 - 398
  • [49] ORPHAN DRUGS
    RHEIN, R
    [J]. BRITISH MEDICAL JOURNAL, 1992, 304 (6825): : 465 - 465
  • [50] THE ORPHAN DRUGS
    KASILO, O
    FIORICA, E
    REGGI, V
    TOGNONI, G
    [J]. MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1986, 6 (03): : 295 - 300
12345